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Background:  Previously, we reported that neonatal porcine pancreatic cells transfected with hepatocyte growth factor (HGF) 
gene in an Epstein-Barr virus (EBV)-based plasmid (pEBVHGF) showed improved proliferation and differentiation compared 
to those of the control. In this study, we examined if pancreatic cells transfected repeatedly with pEBVHGF can be successfully 
grafted to control blood glucose in a diabetes mouse model.
Methods:  Neonatal porcine pancreatic cells were cultured as a monolayer and were transfected with pEBVHGF every other day 
for a total of three transfections. The transfected pancreatic cells were re-aggregated and transplanted into kidney capsules of dia-
betic nude mice or normal nude mice. Blood glucose level and body weight were measured every other day after transplantation. 
The engraftment of the transplanted cells and differentiation into beta cells were assessed using immunohistochemistry.
Results:  Re-aggregation of the pancreatic cells before transplantation improved engraftment of the cells and facilitated neovas-
cularization of the graft. Right before transplantation, pancreatic cells that were transfected with pEBVHGF and then re-aggre-
gated showed ductal cell marker expression. However, ductal cells disappeared and the cells underwent fibrosis in a diabetes mouse 
model two to five weeks after transplantation; these mice also did not show controlled blood glucose levels. Furthermore, pan-
creatic cells transplanted into nude mice with normal blood glucose showed poor graft survival regardless of the type of trans-
fected plasmid (pCEP4, pHGF, or pEBVHGF).
Conclusion:  For clinical application of transfected neonatal porcine pancreatic cells, further studies are required to develop 
methods of overcoming the damage for the cells caused by repeated transfection and to re-aggregate them into islet-like structures.
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INTRODUCTION
The applications of porcine pancreas and pancreatic cells in 
the treatment of diabetes have been studied [1-4]. Specifically, 
there is increasing interest in using neonatal porcine pancreat-
ic cell clusters (NPCCs) due to numerous advantages [5-11]. It 
was shown that 70% of the NPCCs of a three-day-old pig were 
pancreatic duct cells which are known as pancreatic stem cells, 
and 10% were beta cells [12]. Glucose was controlled normally 
in diabetic animal models when NPCCs were transplanted in 
the clustered state to the mouse kidney capsules [10]. There-
fore, NPCCs seem to be a useful source for the future treatment 
of diabetes. However, it takes four to ten weeks after transplan-
tation for NPCCs to differentiate into beta cells [10,13]. Thus, 
insulin treatment should be continued even after transplanta-
tion until hyperglycemia adjusts to normal levels [14]. In addi-
tion, the decreasing survival rate of the transplanted NPCCs 
with long-term exposure to a hyperglycemic environment still 
remains to be addressed [15].
  The hepatocyte growth factor (HGF) was first discovered as 
a major factor of liver growth [16] and has subsequently been 
shown to induce the growth of various cells [17,18]. HGF is 
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thought to differentiate NPCCs into beta cells as NPCCs cul-
tured with recombinant HGF showed increased insulin secre-
tion [19]. 
  Monolayer culture of pancreatic cells can facilitate growth 
factor treatment and gene transfer to promote ductal cell growth 
and differentiation into beta cells. Single cells separated from 
NPCCs were cultured in vitro to a certain extent and gene 
transduced using a retrovirus [12]. The monolayer cultured 
and re-aggregated pancreatic cells were successfully engrafted 
in nude mice and part of the cells was confirmed to have dif-
ferentiated into beta cells four weeks after transplantation [12]. 
In order to aid the differentiation of NPCCs in vivo, gene trans-
fection and re-aggregation of monolayer cultured pancreatic 
cells can be performed before transplantation. However, reports 
of such attempts are rare. 
  In our previous study, HGF gene was cloned in an Epstein-
Barr virus (EBV)-based plasmid (pEBVHGF) and transfected 
to monolayer cultured pancreatic cells [20]. HGF was expressed 
about seven times longer in those cells than in the cells trans-
feced with a conventional plasmid (pHGF). Phosphorylation 
of the HGF receptor, c-MET, was observed three days after the 
transfection of pEBVHGF [20]. When pEBVHGF was trans-
fected to pancreatic cells, an increase in insulin secretion was 
also seen compared with the conventional plasmid transfected 
cells [20]. EBV-based plasmid contains EBNA-1 and oriP se-
quences derived from EBV, and these two were confirmed to 
help the plasmid replicate and remain in the transfected pan-
creatic cells during cell proliferation [21]. NPCCs are primary 
cells and transfection efficiency is relatively low. In a prelimi-
nary experiment, increased transfection efficiency was achieved 
when GFP-expressing plasmid (pEBVGFP) was repeatedly 
transfected to pancreatic cells up to three to four times (data 
not shown). 
  In this study, HGF gene cloned in an EBV-based plasmid 
was repeatedly transfected to pancreatic cells. The cells were 
then re-aggregated and transplanted into normal nude mice 
or diabetic nude mice to examine engraftment and differentia-
tion in vivo. Additionally, blood glucose changes of the mice 
were also analyzed. 
METHODS 
Pancreatic cell preparation
We used Rompun
® (0.15 mL/kg; Bayer Korea, Seoul, Korea) 
and Ketamine (16 mL/kg; Yuhan, Seoul, Korea) to anesthetize 
one- to three-day-old neonatal pigs and removed pancreases. 
The pancreases were minced using 20 cm scissors, and digested 
with collagenase P (1 mg/mL in HBSS) at 37°C for 14 minutes. 
The digested pancreases were filtered using a 500 µm mesh, 
and pancreatic cells that were filtered through the mesh were 
collected. The pancreas tissue that was not fully digested was 
placed in 50 mL tubes and digested again for nine minutes at 
37°C with collagenase P (1 mg/mL in HBSS). The re-digested 
tissue was then filtered using the 500 µm mesh to collect cells. 
The isolated pancreatic cells were cultured for one day in a 150 
mm culture container with F10 culture medium. The cultured 
NPCCs were then collected in 50 mL conical tubes and centri-
fuged at 37°C for nine minutes to remove supernatant prior to 
adding 10 mL of cell dissociation solution (Sigma-Aldrich, St. 
Louis, MO, USA). NPCCs were separated into single cells, and 
3×10
6 cells were placed in 100 mm culture dishes with DMEM 
(low-glucose) medium. The pancreatic cells were then cul-
tured in an incubator at 37°C with 5% CO2. 
Plasmid transfection to monolayer cultured pancreatic 
cells
EcoRV and StuⅠ were used in order to remove the oriP and 
EBNA-1 sequences from pEBVHGF, resulting in pHGF [20]. 
An empty EBV-based plasmid, pCEP4, was also used as a con-
trol [20]. Plasmid (5 µg) and lipofectamine 2000 (Invitrogen, 
Carlsbad, CA, USA) were mixed each with 500 µL Opti-MEM 
(GIBCO, Grand Island, NY, USA) at room temperature; the 
two liquids were then carefully mixed together and incubated 
for 30 minutes. 
  After separation from neonatal pigs, pancreatic cells were 
cultured as a monolayer for five days prior to transfection. For 
transfection, the culture medium was replaced with 5 mL of 
serum-free DMEM (low-glucose) and the cells were then in-
cubated with the prepared DNA-lipofectamine 2000 for five 
hours at 37°C and 5% CO2. The culture medium was changed 
to DMEM (low-glucose) containing 10% FBS after five hours, 
and incubation was continued. Using this method, plasmids 
were transfected into pancreatic cells three times every two 
days.
Re-aggregation of the monolayer cultured pancreatic cells 
After removing the culture medium, 5 mL of cell dissociation 
solution (Sigma-Aldrich) was added to the culture dish and 
NPCCs were harvested. The cells were placed in a 15 mL coni-
cal tube and centrifuged for 3 minutes at 1,200 rpm. The cells Seo MK, et al.
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grown in eight to ten 100 mm culture dishes were combined 
in one 50 mL conical tube. The cells in the 50 mL tube was 
centrifuged for three minutes, the supernatant was removed, 
and the pancreatic cells were resuspended by adding 1.5 mL of 
DMEM (low-glucose). The cells were transferred to a 15 mL 
conical tube and were then set with the cover slightly open to 
carry out re-aggregation for two hours in a 37°C incubator 
with 5% CO2. The re-aggregated pancreatic cells were then 
carefully placed in the middle of a 100 mm culture dish to pre-
vent scattering and incubated for 48 hours before used for 
transplantation. 
Preparation of the diabetes model mice
The breeding, management, and all of the transplantations of 
the immunodeficient seven- to eight-week-old mice (CAnN.
Cg-Foxn1 nu/Crlj0ri; Orient Bio Inc., Seongnam, Korea) were 
performed in a Semi-SPF sector. These mice were fasted for 
eight hours, and 220 mg/kg of streptozotocin was injected into 
each animal. Blood from the tail vein was collected every day 
and blood glucose levels were measured. When the blood glu-
cose level was greater than 400 mg/dL for five days, the mouse 
was classified as a diabetic and was used for pancreatic cell 
transplantation. This research was performed after approval 
from the Animal Experimentation Ethics Committee of The 
Catholic University of Korea. Proper procedure and regula-
tions were strictly followed throughout the experimental pro-
cess.
Transplanting re-aggregated pancreatic cells into mice
The re-aggregated pancreatic cells were centrifuged for three 
minutes in 50 mL conical tubes at 1,200 rpm and the superna-
tant was removed. The cells were transferred to 1.5 mL EP-tubes 
(4,000-5,000 IEq [islet equivalent]) and centrifuged for anoth-
er three minutes. To transplant the prepared cells, they were 
let settle at the bottom of PE-50 tube (Becton Dickinson, Frank-
lin Lakes, NJ, USA). Normally, the amount of pancreatic cells 
required to transplant into one mouse was obtained from one 
neonatal pig after in vitro culture, plasmid transfection, and 
re-aggregation processes.
  The mice were anesthetized with a peritoneal injection of 
0.1 mL Ketamine and Rompun
® mixed in a 5:1 ratio. The kid-
ney was exposed from the mouse through the left flank, and 
the membrane of the kidney was incised with an injection 
needle. The pancreatic cells were injected into the membrane 
of the kidney from the PE-50 tube by applying weak and uni-
form pressure using a Hamilton syringe. A high temperature 
cautery (Bovie Medical Co., St. Petersburg, FL, USA) was used 
to close the incision. After repositioning the kidney within the 
body, we sutured the peritoneum and then the skin using 
punch stitches. After transplantation, we measured weight and 
blood glucose levels from tail blood draws at two-day intervals, 
between 4 PM and 5 PM. 
Immunohistochemical staining
The kidneys of pancreatic cell-transplanted mice were fixed 
with formalin at room temperature for 16 hours and embed-
ded in paraffin. Then, the kidney was sliced into 4 µm pieces 
and mounted onto slides. Paraffin was removed using xylene, 
and either guinea pig anti-insulin (1:100; Invitrogen) or rabbit 
anti-pancytokeratin (1:100; Zymed, San Francisco, CA, USA) 
antibodies were added and incubated at 4°C for 16 hours. Af-
ter that, the slides were reacted at room temperature for two 
hours with either rhodamine-conjugated anti-guinea pig IgG 
(1:100; Jackson ImmunoResearch, West Grove, PA, USA) or 
FITC-conjugated anti-rabbit IgG (1:100; Jackson ImmunoRe-
search) secondary antibodies. The tissue was covered using 
mounting solution, which includes DAPI. The tissue was then 
observed under a fluorescence or confocal microscope.
Cell viability assay
CCK-8 solution (Cell Counting Kit-8; Dojindo, Kumamoto, 
Japan) was diluted with fresh culture medium at a 1:10 ratio. 
The diluted CCK-8 solution was added at 110 µL/well to a 96-
well plate of cultured pancreatic cells and incubated for three 
hours at 37°C with 5% CO2. The change in the absorbance at 
450 nm was assessed using an ELISA analyzer (Model 680 Mi-
croplate Reader; Bio-Rad, Hercules, CA, USA).
RESULTS
Successful transplantation of the NPCCs which were not 
manipulated in vitro 
NPCCs isolated as clusters without incubation in vitro or sepa-
ration into single cells, were transplanted into the kidney cap-
sules of normal nude mice (Fig. 1). From two weeks after trans-
plantation, some of the cells expressed insulin and undifferen-
tiated pancreatic cells were also present. After eight weeks, most 
of the cells had differentiated into beta cells which formed is-
lets and produced insulin (Fig. 1).Transfection-impaired engraftment of pancreatic cells
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Effect of the status of transplanted pancreatic cells on the 
transplantation efficacy
After monolayer culture, transplantation efficacy was compared 
between single cell state and re-aggregated pancreatic cells. 
Within three days of the birth of the newborn pig, NPCCs were 
separated and dispersed as single cells. After seven days of 
monolayer culture, two-day re-aggregation was performed 
with some cells, and the remaining cells were cultured as a 
monolayer for two more days. The monolayer cultured pancre-
atic cells which were harvested as single cells (3.6×10
6 cell/
mouse) or the re-aggregated cells (4,000-5,000 IEq/mouse) 
were then transplanted into the mouse kidney capsules. The 
grafts were harvested fourteen days after the transplantation 
and examined through hymatoxylin staining. The survival rate 
of transplanted single cells was low in mouse kidney capsules, 
whereas the re-aggregated pancreatic cells had a high survival 
rate (Fig. 2, upper panel). Some re-aggregated pancreatic cells 
differentiated into insulin-secreting beta cells, and blood ves-
sels were generated between transplanted cells (Fig. 2, lower 
panel).
Effect of repeated transfection on pancreatic cell viability 
Pancreatic cells in monolayer culture were repeatedly trans-
fected with pCEP4, pHGF, or pEBVHGF, and the changes in 
cell viability were examined. When pancreatic cells were trans-
fected once with plasmid, the cell viability decreased slightly 
compared to that of the untransfected cells. When the cells were 
transfected twice, the cell viability decreased further (Fig. 3). 
However, cell viability did not decrease further when transfec-
tion was performed three times (Fig. 3). Thus, pancreatic cells 
were transfected three times for our future experiments. 
Changes in blood glucose of diabetic model mice which 
were transplanted with gene transfected pancreatic cells 
Whether the pEBVHGF-transfected pancreatic cells have ef-
fect on the treatment of diabetes was examined. For this, body 
weight and blood glucose changes of the diabetic mice models 
were measured in two-day intervals after re-aggregated cells 
which were transfected with pHGF or pEBVHGF were trans-
planted (4,000 IEq/mouse). We observed that the mice trans-
planted with cells transfected with any of the plasmids did not 
recover to their normal weight. However, pEBVHGF group 
had a tendency to maintain a slightly higher body weight at 
the early stage when compared to pHGF group (Fig. 4). 
Characteristics of the pancreatic cells right after re-
aggregation
 The features of the pancreatic cells were analyzed just before 
transplantation. After consecutive triple pEBVHGF transfec-
tion, the cells were re-aggregated for two days. The re-aggre-
Fig. 1.  Successful transplantation of neonatal porcine pancre-
atic cell clusters (NPCCs) in normal mice. NPCCs were har-
vested and transplanted immediately into the kidneys of nor-
mal nude mice without any manipulation. Two and eight 
weeks after transplantation, transplanted NPCCs were exam-
ined using immunohistochemistry. Insulin is stained red and 
pancytokeratin is stained green, while nuclear staining is 
shown in blue. 
2 week 8 week
Fig. 2.  Effect of re-aggregation on in vivo survival of pancre-
atic cells after transplantation. Single-cell state or re-aggregat-
ed pancreatic cells were transplanted in the kidney capsule of 
normal mice. The graft was examined following hematoxylin 
staining or immunohistochemistry two weeks after transplan-
tation. The black arrow point to blood vessels within the graft. 
Insulin is shown in red and pancytokeratin is shown in green, 
while nuclear staining is shown in blue. NPCCs, neonatal por-
cine pancreatic cell clusters.
Hematoxylin stain
Insulin (red) / PanCK (green) / 
DAPI (blule)
R
e
-
a
g
g
r
e
g
a
t
e
d
 
N
P
C
C
s
S
i
n
g
l
e
 
c
e
l
l
 
s
t
a
t
e
 
N
P
C
C
sSeo MK, et al.
76 Diabetes Metab J 2011;35:72-79 http://e-dmj.org
gated pancreatic cells showed compact round shape, and the 
expression of the pancreatic cell marker, pancytokeratin, was 
confirmed in most of the cells (Fig. 5). In addition, some insu-
lin-expressing cells were observed (Fig. 5).
Characteristics of the graft after transplantation of 
pancreatic cells
After pancreatic cells were transplanted into diabetic mouse 
model, some mice died of polyuria, hypothermia, and other 
problems that developed as a result of hyperglycemia during 
the short observation period. Two out of four mice from the 
pHGF group and three out of four mice from the pEBVHGF 
group survived to the completion of the study. The survivors 
Fig. 3.  Effect of repeated transfection on cell viability. Pancreatic cells were transfected repeatedly with pCEP4, pHGF, or pEB-
VHGF every other day up to three times. Twenty-four hours after each transfection, viable cell count was analyzed using a CCK-
8 kit. Cell viabilities are expressed as percent of untransfected control cells. Data are presented as the mean ± standard error of 
three independent experiments.
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Fig. 4.  Concentrations of blood glucose and body weight fol-
lowing transplantation of pancreatic cells transfected with 
pHGF or pEBVHGF. Pancreatic cells were transfected with 
pHGF or pEBVHGF, and re-aggregated. The re-aggregated 
cells were transplanted into the type 1 diabetes mouse model. 
Blood glucose level (A) and body weight (B) were measured 
every other day. Time 0 indicates the day of pancreatic cell 
transplantation.
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Fig. 5.  Pancytokeratin and insulin expressions in the pancre-
atic cells transfected three times with pEBVHGF and re-aggre-
gated. The cells were fixed and stained right after transplanta-
tion into the diabetes mouse model. Insulin is shown in red 
and pancytokeratin is shown in green, while nuclear staining 
is shown in blue. Imaging was performed with a confocal mi-
croscope (400×objective). Transfection-impaired engraftment of pancreatic cells
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had their kidneys extracted, and the expressions of insulin and 
pancytokeratin were confirmed using immunohistochemical 
staining. Unlike what we observed in Fig. 5, nearly all mouse 
grafts that survived for two to five weeks underwent fibrosis, 
and the tissue grafts showed scattered tiny holes (Fig. 6).
Analysis of pancreatic cells transplanted into normal nude 
mice
To check whether the low survival rates of pancreatic cells in 
the diabetic mouse model was due to high glucose toxicity, the 
cells transfected with pHGF or pEBVHGF were transplanted 
into normal nude mice. pCEP4 (control plasmid), pHGF, and 
pEBVHGF were each transfected to pancreatic cells through 
three transfections each, and then the cells were re-aggregated. 
The prepared cells were transplanted into normal nude mice 
(pCEP4 group [n = 4], pHGF group [n = 5], and pEBVHGF 
group [n = 5]). After one, two, and eight weeks, the graft sur-
vival was evaluated using immunohistochemical staining. Even 
in this case, regardless of the type of transfected plasmids, the 
majority of transplanted cells underwent fibrosis as early as 
one week after transplantation, leaving only a few insulin-pro-
ducing cells and pancytokertin positive cells (Fig. 7).
DISCUSSION
In this study, we observed that re-aggregated pancreatic cells 
showed improved engraftment than the cells in single-cell state 
when they were transplanted into immunodeficient mouse 
kidney capsules. These results are comparable to the results re-
ported by Tatarkiewicz et al. [12]. Pancreatic cells in kidney 
capsules were unable to form islets two weeks after transplan-
tation in our study, similar to what they [12] observed four 
weeks after transplantation. However, the cells appeared as 
dense cluster, and blood vessel formation within the cell clus-
ter was observed at two weeks after transplantation. Also, some 
of the cells were able to produce insulin, although the majority 
was not. Glucose-stimulated insulin secretion was higher in 
pseudo-islet forms of MIN 6 cells, a type of β-cell, compared 
to what was observed in monolayer cultured MIN 6 cell [22]. 
Thus, re-aggregated pancreatic cells seem to be more effective 
for engraftment and insulin production possibly through the 
increased cell density and, interaction between cells.
  When monolayer cultured and then re-aggregated pancre-
atic cells were transplanted, there was no islet formation after 
two and four weeks [12]. In contrast, the islets were formed 
when NPCCs were separated and immediately transplanted 
Fig. 6.  No expression of insulin or pancytokeratin in the 
transplanted pancreatic cells in a diabetes mouse model. Pan-
creatic cells were transfected three times with pHGF or pEB-
VHGF, re-aggregated, and transplanted into a type 1 diabetes 
mice. Survival and differentiation of the transplanted cells 
were examined using immunohistochemistry two and five 
weeks after transplantation. Insulin is stained red and pancy-
tokeratin is stained green, while nuclear staining is shown in 
blue. 
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Fig. 7.  Loss of pancreatic cells transplanted into normal mice. 
Pancreatic cells were transfected three times with pCEP4, 
pHGF, or pEBVHGF and then re-aggregated. Normal nude 
mice were transplanted with the re-aggregated pancreatic cells 
in the kidney capsule. The transplanted cells were examined 
using immunohistochemistry one, two, and eight weeks after 
transplantation. Insulin is shown in red and pancytokeratin is 
shown in green, while nuclear staining is shown in blue.
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without further in vitro manipulation as shown in Fig. 1 and 
published by others [23-25]. These discrepancies might be due 
to the loss of extracellular matrix or other factors which are re-
quired for islet structure formation, during the NPCCs disper-
sion into single cells. Even if the cells are re-aggregated, these 
substances or factors might not be able to easily recovered [10, 
12,26].
  Unlike in the previous study where the re-aggregated pan-
creatic cells were simply transplanted into nude mouse [12], 
we transfected gene to monolayer cultured pancreatic cells 
and re-aggregated before transplantation to promote differen-
tiation of duct cells into beta cells. Since the pancreatic cells 
are primary cells, to overcome the low transfection efficiency, 
we repeated the gene transfection. Even though repeated trans-
fection resulted in decreased cell viability, the transfection effi-
ciency was overall increased (data not shown). We expected 
transplanting pancreatic cells that were repeatedly transfected 
with genes, would facilitate beta cell differentiation and cell 
survival in vivo. However, transfected cells were unable to sur-
vive in diabetic mouse models, demonstrating that this ap-
proach is not a candidate for a possible diabetes treatment. 
During the first few days after transplantation of the cells trans-
fected with pEBVHGF, slight drop in blood glucose was ob-
served in diabetic nude mice. This is possible because the pan-
creatic cells remained intact at the early stage before experi-
encing fibrosis or apoptosis.
  To test if high glucose toxicity hampered survival of pancre-
atic cells in the diabetes mouse models, we transplanted the 
transfected cells into normal nude mice. The pancreatic cells 
were unable to successfully engraft in this case, either. Thus, 
high glucose toxicity would not be the main cause of failed en-
graftment of pancreatic cells in vivo. There are many likely 
causes for the failure of engraftments. Damage to the cells 
caused by the increase in culture period, transfection, centrif-
ugation, and other in vitro manipulation could be one reason. 
It took up to nine days till prepare cells for transplantation if 
they were monolayer cultured and re-aggregated without trans-
fection. However, it took thirteen days if the pancreatic cells 
received three consecutive transfections, and then re-aggregat-
ed prior to transplantation. Therefore, a four-day increase in 
the in vitro incubation period, as well as exposure to the re-
peated lipofectamine transfection are thought to be the main 
interfering points in successful engraftment of re-aggregated 
cells. As the pancreatic cells that underwent transfection and 
re-aggregation expressed pancytokeratin and insulin, these 
processes seem to affect the cells further under in vivo condi-
tions than during in vitro culture. 
  Our results demonstrate that when pancreatic cells repeat-
edly transfected with pEBVHGF were transplanted into dia-
betic animal models, no appreciable therapeutic effect was ob-
served. In our in vitro experiments, when pancreatic cells were 
transfected with pEBVHGF, the HGF receptor was expressed 
and phosphorylated [20]. The increases in cell growth and in 
the expression of insulin were also confirmed [20]. Thus, fur-
ther study is necessary to minimize the handing time from the 
separation of the pancreatic cells to transplantation into the 
animal models, and to reduce cell damage during gene trans-
fection, re-aggregation, and the transplantation processes. Also, 
if we can develop a method for clustering the cells to form is-
let-like structures, successful results for diabetes treatments 
using neonatal porcine pancreatic cells may be achieved in the 
future. 
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